India’s pharmaceutical ecosystem is witnessing remarkable transformation in 2026, driven by advancements in drug development, expanding manufacturing capabilities, stringent quality standards, and the growing demand for accessible healthcare solutions. As the country strengthens its position as a global pharmaceutical powerhouse, the importance of specialized solution providers has become increasingly significant in supporting the industry's evolving requirements.
At the heart of this progress are pharmaceutical ingredients manufacturers and pharmaceutical... >>More
Dr Rajiv Chhibber, Joint Forum Coordinator, Association of Indian Medical Device Industry (AiMeD)
Dr Kuber Jagdale, President - API Business Unit, Emcure Pharmaceutical Business Formation
Pushkar Kulkarni, General Manager, Johnson & Johnson Innovative Medicine, (India & South Asia)
Jayakumar A V, President (Quality), Ajanta Pharma
Anil Suri, Chief Commercial Officer, Sahajanand Medical Technologies
Dr. Anudeep Sandhu, Director - Medical Affairs & Clinical Affairs, Terumo India
Dr Sadhna Joglekar, Senior VP & Head - Global Drug Development India, Novartis